An interventional study of white noise and pink noise in Pain (Visceral, Somatic, or Neuropathic) and Anxiety Acute, sponsored by Tokat Gaziosmanpasa University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-07-27.
Sponsored by Tokat Gaziosmanpasa University · Not applicable, Interventional, and Supportive care
Among 20 studies in Pain by Tokat Gaziosmanpasa University — 4 open to participants now, 4 under way, none of them phase 3. Pain · Tokat Gaziosmanpasa University.
Among the 20 studies in Pain by Tokat Gaziosmanpasa University, this one is the 3rd largest by planned enrollment of the 16 interventional ones that give a count, is one of 2 that started in 2026, is one of 15 with no phase, and was the 19th registered.
10,060 studies on the registry are indexed under Pain; 1,651 are open to participants now.
Browse Pain studies →4 of the 20 studies in Pain by Tokat Gaziosmanpasa University are open now, in 1 country. Recruiting first, the newest first:
Tokat Gaziosmanpasa University · Sites in Turkey
Ages 18+ · Women only · Healthy volunteers
Tokat Gaziosmanpasa University · Sites in Turkey
Ages 18–70 · Healthy volunteers
Tokat Gaziosmanpasa University · Sites in Turkey
Ages 19–35 · Women only · Healthy volunteers
By country, each count listing its studies:
Of the 929 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 222 take healthy volunteers.
This study: 6 Years to 12 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 2 started in 2026.
This study's planned enrollment of 150 is above the median of 66 across 8,497 interventional studies indexed under Pain.
Median enrollment 84 across the 16 interventional studies, 133 across the 4 observational. Of the 13 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Tokat Gaziosmanpasa University is the lead sponsor of 170 studies on the registry; 38 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 20 studies in Pain by Tokat Gaziosmanpasa University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study is a prospective, three-arm, single-blind, randomized controlled clinical trial designed to evaluate the effectiveness of non-pharmacological sound-based interventions on pain and anxiety in pediatric patients. The study will be conducted at a university hospital with 150 children aged 6-12 years who require peripheral intravenous (IV) catheterization. Participants will be randomly assigned to three groups: a white noise group, a pink noise group, or a control group (standard care). Sound interventions (white or pink noise at 50-55 dB) will be administered via noise-canceling headphones for 5 minutes before and during the IV procedure. The primary outcomes will be pain levels assessed by the Visual Analog Scale (VAS) and the Wong-Baker FACES Pain Rating Scale, and anxiety levels assessed by the Children's Fear and Anxiety Scale (CFAS). The study aims to provide evidence-based, safe, and cost-effective alternatives to pharmacological pain management in pediatric clinical procedures.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this group will be exposed to white noise at a constant intensity of 50-55 dB via noise-canceling headphones for 5 minutes before and during the peripheral intravenous (IV) catheterization procedure.
Behavioral: white noise
Participants in this group will be exposed to pink noise at a constant intensity of 50-55 dB via noise-canceling headphones for 5 minutes before and during the peripheral intravenous (IV) catheterization procedure.
Behavioral: pink noise
Participants in this group will receive standard care during the peripheral intravenous (IV) catheterization procedure. Headphones will be worn, but no sound intervention will be administered.
White noise will be administered at a constant intensity of 50-55 dB using noise-canceling headphones for 5 minutes before and during the peripheral intravenous (IV) catheterization procedure.
Also known as: sound-based intervention
Participants in this group will be exposed to pink noise at a constant intensity of 50-55 dB via noise-canceling headphones for 5 minutes before and during the peripheral intravenous (IV) catheterization procedure.
pain intensity
Pain intensity will be measured using the Face, Legs, Activity, Cry, Consolability (FLACC) Behavioral Pain Scale, ranging from 0 to 10, where higher scores indicate greater pain intensity.
Time frame: During the peripheral intravenous (IV) catheterization procedure.
Anxiety level
Anxiety level will be measured using the Modified Yale Preoperative Anxiety Scale (m-YPAS), ranging from 23.33 to 100, where higher scores indicate greater anxiety levels.
Time frame: During the peripheral intravenous (IV) catheterization procedure.
Plan to share: Yes — De-identified individual participant data will be made available to researchers upon reasonable request, subject to institutional review board (IRB) approval and informed consent requirements.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report
Time frame: Data will be available starting 6 months after the study completion date and will remain available for 5 years.
Access criteria: Researchers who provide a methodologically sound proposal may request access to the de-identified participant-level data. Proposals should be directed to the principal investigator. Access will be granted after institutional review board (IRB) approval and the signing of a data use agreement.
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for Sep 2026, 0 months later.
Of 3,734 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 0 months is below that.
Counting every sponsor, half of 3,833 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tokat Gaziosmanpasa University →